Yale University

Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial.

TitlePersistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial.
Publication TypeJournal Article
Year of Publication2009
AuthorsMaru, Duncan Smith-Rohrberg, Robert Douglas Bruce, Mary Walton, Sandra A. Springer, and Frederick L. Altice
JournalJournal of acquired immune deficiency syndromes (1999)
Volume50
Issue2
Pagination176-81
Date Published2009 Feb 1
ISSN1525-4135
KeywordsAdult, Anti-HIV Agents, CD4 Lymphocyte Count, Directly Observed Therapy, Female, HIV Infections, HIV-1, Humans, Male, Middle Aged, Patient Compliance, RNA, Viral, Self Administration, Social Support, Substance-Related Disorders, Treatment Outcome
AbstractAlthough directly administered antiretroviral therapy (DAART) has demonstrated impressive biological benefits compared with self-administered therapy (SAT) among drug users, the persistence of DAART after transition to SAT has not been examined.
DOI10.1097/QAI.0b013e3181938e7e
Alternate JournalJ. Acquir. Immune Defic. Syndr.

External Links